Search

Diabetes is a metabolic disease which has hyperglycaemia resulting from defects in insulin secretion or action. HbA1C is one of the most reliable test used for estimation of glycaemic index. Diabetes is often accompanied by undiagnosed dyslipidaemia, characterized by increased triglyceride level, decreased high-density lipoprotein levels and increase in low-density lipoprotein (LDL) particles. Diabetes is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD). The purpose of this study was to correlate lipid parameters with different levels of HbA1c to assess dyslipidaemia with diabetic status. An observational study was conducted in biochemistry laboratory at Gandhi Hospital, Telangana.After informed consent, 5ml of venous blood sample was collected in plain tube and EDTA tube from diabetic and apparently non diabetic patients. Estimation of serum triglycerides was done by glycerol phosphate oxidase peroxidase, serum cholesterol by cholesterol oxidase method, serum HDL by direct clearance method in Beckmann Coulter AU 500 and HbA1c was estimated by high performance liquid chromatography in Bio-Rad D10.A total of 90 samples were divided into 3 groups according to their HbA1c results. Group 1 with HbA1c less than 5.6, Group 2 with HbA1c 5.6-7 and Group 3 with HbA1c more than 7.The present study showed no variation in the lipid profile in Group1 with HbA1c < 5.6. In Group 2 with HbA1c between 5.6-7, there was significant increase in LDL cholesterol. In Group 3 with HbA1c >7 there was marked increase in LDL, serum triglyceride. Hence we can conclude that dyslipidemia is increased in poor glycemic control and evaluation of HbA1c may also be used as a predictor of dyslipidaemia in diabetics.

Objectives: Establishing teaching policies which improve the quality of student learning experience and thereby, enhance the overall learning outcome. Teaching and learning are inherently intertwined, and this necessitates a holistic approach towards the development of novel teaching methodologies.Sustainable quality teaching policies require long-term, non-linear efforts and thus call for a permanent commitment from the teaching faculty. In general, certain quantitative standards/measures can be employed to gauge the efficacy of teaching. In this article, we present an observational study conducted at a recently established Govt. Medical College at Nizamabad in the State of Telangana. A novel teaching-learning framework was formulated and implemented. The efficacy of the framework was measured by gauging various parameters post-implementation of the policy.The proposed framework included policies related to the following aspects: Attendance Specific teaching-learning programme for Practical procedures Formative assessments followed by feedback sessions reflecting on their performance Conducting periodical tests Formulation of questions by Students for Mock Orals Conducting Quiz Programmes As shown by certain quantitative metrics, the implementation of the proposed framework has resulted in the improvement of academic performance of the students. Material and Methods: The study was based on data analysis of summative marks records, after each year. The data was collected for about 400 students over a period of 4 years. Results: The efficacy of the proposed teaching method was analysed by the gauging the academic performance of students prior to and post implementation of the policy framework. The results indicate significant improvement of student academic performance after the implementation of the proposed policy framework. Conclusion: Evolving departmental policies with specific teaching learning programmes will help to improve the academic performance through motivation and better understanding of subject. Administering specific teaching learning programmes with strict attendance policy plays a role in improving the academic performance of the students. Keywords: Attendance policy, Specific teaching learning programmes.

COVID 19 is known to cause immune dysregulation and vitamin D is a known immunomodulator. This study aims to objectively investigate the impact of Pulse D therapy in reducing the inflammatory markers of COVID-19. Consented COVID-19 patients with hypovitaminosis D were evaluated for inflammatory markers (N/L ratio, CRP, LDH, IL6, Ferritin) along with vitamin D on 0th day and 9th/11th day as per their respective BMI category. Subjects were randomised into VD and NVD groups. VD group received Pulse D therapy (targeted daily supplementation of 60,000 IUs of vitamin D for 8 or 10 days depending upon their BMI) in addition to the standard treatment. NVD group received standard treatment alone. Differences in the variables between the two groups were analysed for statistical significance. Eighty seven out of one hundred and thirty subjects have completed the study (VD:44, NVD:43). Vitamin D level has increased from 16 ± 6 ng/ml to 89 ± 32 ng/ml after Pulse D therapy in VD group and highly significant (p 0.05). The difference in the reduction of markers between the groups (NVD vs VD) was highly significant (p

Introduction: COVID 19 is known to cause immune dysregulation and vitamin D is a known immunomodulator. This study aims to objectively investigate the impact of Pulse D therapy in reducing the inflammatory markers of COVID-19. Materials/ Methods: Consented COVID-19 patients with hypovitaminosis D were evaluated for inflammatory markers (N/L ratio, CRP, LDH, IL6, Ferritin) along with vitamin D on 0th day and 9th / 11th day as per their respective BMI category. Subjects were randomised into VD and NVD groups. VD group received Pulse D therapy (targeted daily supplementation of 60,000 IUs of vitamin D for 8 or 10 days depending upon their BMI) in addition to the standard treatment. NVD group received standard treatment alone. Differences in the variables between the two groups were analysed for statistical significance. Results: Eighty seven out of one hundred and thirty subjects have completed the study (VD:44, NVD:43). Vitamin D level has increased from 15.65 ± 5.54 ng/ml to 88.96 ± 31.55 ng/ml after Pulse D therapy in VD group and highly significant (p0.05) . The difference in the reduction of markers between the groups (NVD vs VD) was highly significant (pConclusions: Therapeutic improvement in vitamin D to 80-100 ng/ml has significantly reduced the inflammatory markers associated with COVID-19 without any side effects. Hence, adjunctive Pulse D therapy can be added safely to the existing treatment protocols of COVID-19 for improved outcomes.

Background: Coagulation tests are widely applied in clinical practice, among which PT and aPTT are the most commonly done. Among many preanalytical conditions –time, temperature and storage conditions are few of the factors affecting the results of samples. This study aims to compare PT and aPTT values in primary tubes and sample aliquots after 4 hours duration with the initial value. Materials & Methods : An observational study was done at Central Diagnostic Laboratory, Gandhi Hospital, Secunderabad, T.S. Samples were collected in citrated tubes, centrifuged, PT and aPTT were processed with plasma of primary tubes. Sufcient quantity of plasma was aliquoted immediately from primary tubes and kept at room temperature for 4 hours after which the plasma of primary tubes and aliquots were re-analyzed separately and values were compared. Results: Pearson correlation was performed to show the relation. PT and aPTT values obtained in the primary tube and aliquot were correlating with the initial value (PT-r =0.833,0.831 respectively) and (aPTT-r =0.97,0.87 respectively) and also with each other (PT-r =0.99) and (aPTT-r =0.90) respectively. There is no statistical signicant difference in PT of primary tube and aliquots when compared to initial PT (p>0.01). Incase of APTT there is statistically signicant difference in primary tube and aliquot when compared to initial value (p0.01). Conclusion: The present study shows no difference of PT values in aliquots and primary tube when compared to initial value, whereas APTT values differ from initial values in samples stored for more than 4 hours in primary tube and aliquot.